Alternative Funding Mechanisms for Biologics

Advancing biologics through commercialization is a long process. Traditional funding routes such Initial public offerings (IPO) are less common, venture capital and private equity firms can be more selective, and the mergers & acquisition (M&A) option isn’t always available for pre-clinical and early-stage companies. Fortunately, traditional funding routes are not the only options for advancing … Read more

Who’s Who in San Antonio: Gregory C. Ippolito, Ph.D.

Gregory C. Ippolito, Ph.D. brings deep expertise in approaches that reveal fundamental mechanisms of a body’s immune response to infection, as well as responses where antibodies mistakenly attack healthy organs and tissues in autoimmune disorders such as lupus. He and collaborators have identified antibody repertoires elicited by vaccines or treatments. They designed a protocol that … Read more

Who’s Who in San Antonio: Paolo Casali, M.D.

Paolo Casali, M.D. has spent almost 5 decades in the areas if immunology, microbiology and molecular genetics. Dr. Casali studies how certain genes are turned on or off in the immune system and looks at how these changes affect the body’s ability to make antibodies; proteins that help fight infections. The Casali lab studies how … Read more

BioMedSA New Members: June 2024

BioMedSA’s Board of Directors approved 4 new memberships in June 2024: Eppendorf, Lone Star National Bank, Pizarro Allen, and Raven Innovations. Eppendorf is a German based company that seeks to support research in academic, commercial, and industrial spaces by developing and manufacturing a variety of products and services for use in laboratories in pharmaceutical, biotech, … Read more

Who’s Who in San Antonio: Alison Wiesenthal, MD, FACP, FAAHPM

Dr. Alison Wiesenthal is the current Chair of the Department of Rehabilitation Medicine at Brooke Army Medical Center (BAMC). Stepping into this role in March of 2020, Wiesenthal became the first civilian to hold the position. She founded the first interdisciplinary Palliative Care Service to the Department of Defense in 2017. Her current role also … Read more

Who’s Who in San Antonio: Laurence Morel, PhD

Dr. Laurence Morel is investigating the mechanisms of lupus pathogenesis. The ultimate goal of her work is to establish better clinical management and therapeutic targets by identifying lupus susceptibility in genes or pathways.  Her current focus is CD4 T cells and B cells. In 2022, the University of Texas System awarded Dr. Morel $1.4M to establish … Read more

BioMedSA New Members: April 2024

BioMedSA’s Board of Directors approved 3 new memberships in April 2024: GoldiloxBio, Maribel Gonzalez and TECHspace. GoldiloxBio develops novel assays to provide predictive pre-clinical toxicity and efficacy testing to the BioPharma market. Maribel Gonzalez is the Co-Founder and Owner of Vitality Chronic Care Management as well as a leader in the development of Platelet-Rich Plasma … Read more

Biofest Invest 2024 Pitch Winners

  After a rigorous application and acceptance process, pitch development support and in-person pitching, the Biofest Invest 2024 winner is NeuraStasis, as startup.  NeuraStasis seeks to improve health outcomes for stroke survivors through the use of neurostimulation. The Houston startup was founded in 2021 by Dr. Kirt Gill and Joe Upchurch in an effort to … Read more

Biofest Days 2024

Biofest Days was a week-long celebration of the Healthcare and Bioscience industry held from April 16-April 20 that highlighted the assets and support structure of a thriving and growing ecosystem. Centering around the Biofest Invest startup conference and pitch competition, BioMedSA extended the invitation to local, regional, and national organizations to participate in Biofest Days … Read more

BioMedSA New Members: March 2024

BioMedSA’s Board of Directors approved 2 new memberships in February 2024: ALS Association and Capital Factory Established in 1985, the ALS Association (Amyotrophic Lateral Sclerosis Association) is the only national nonprofit organization fighting ALS on every front. Seeking to lead the way in global research, providing assistance for people with ALS, coordinating multidisciplinary care through … Read more

Login

Welcome back! Login below